These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8179860)

  • 1. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.
    Quak J; van Dongen G
    Eur Arch Otorhinolaryngol; 1994; 251(1):1-5. PubMed ID: 8179860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
    Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
    de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
    Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunodiagnosis of lymph node metastases in head and neck cancer.
    de Bree R; Roos JC; Verel I; van Dongen GA; Snow GB
    Oral Dis; 2003 Sep; 9(5):241-8. PubMed ID: 14628891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies for diagnosis and therapy of squamous cell carcinoma of the head and neck.
    Gripp FM; Quak J; Leverstein H; Schrijvers A; Gerretsen M; Brakenhoff R; Van Dongen G; Snow GB; Rapoport A
    Sao Paulo Med J; 1994; 112(3):612-21. PubMed ID: 7638523
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT.
    Baum RP; Adams S; Kiefer J; Niesen A; Knecht R; Howaldt HP; Hertel A; Adamietz IA; Sykes T; Boniface GR
    Acta Oncol; 1993; 32(7-8):747-51. PubMed ID: 8305222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
    Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
    Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoscintigraphy of squamous cell carcinoma in the head and neck region.
    Heissler E; Grünert B; Barzen G; Fritsche L; Hell B; Felix R; Bier J
    Int J Oral Maxillofac Surg; 1994 Jun; 23(3):149-52. PubMed ID: 7930767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.
    de Bree R; Roos JC; Quak JJ; den Hollander W; van den Brekel MW; van der Wal JE; Tobi H; Snow GB; van Dongen GA
    J Nucl Med; 1994 May; 35(5):775-83. PubMed ID: 8176458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
    Stroomer JW; Roos JC; Sproll M; Quak JJ; Heider KH; Wilhelm BJ; Castelijns JA; Meyer R; Kwakkelstein MO; Snow GB; Adolf GR; van Dongen GA
    Clin Cancer Res; 2000 Aug; 6(8):3046-55. PubMed ID: 10955783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
    Schrijvers AH; Quak JJ; Uyterlinde AM; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Sep; 53(18):4383-90. PubMed ID: 8364934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT.
    Adamietz IA; Baum RP; Schemman F; Niesen A; Knecht R; Saran F; Tieku S; Boniface GR; Hör G; Böttcher HD
    J Nucl Med; 1996 Dec; 37(12):1942-6. PubMed ID: 8970510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical screening of monoclonal antibodies 323/A3, cSF-25 and K928 for suitability of targetting tumours in the upper aerodigestive and respiratory tract.
    De Bree R; Roos JC; Quak JJ; Den Hollander W; Snow GB; Van Dongen GA
    Nucl Med Commun; 1994 Aug; 15(8):613-27. PubMed ID: 7970443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area].
    Adamietz IA; Schemmann F; Baum RP; Knecht R; Saran F; Mose S; Thilmann C; Hör G; Böttcher HD
    Strahlenther Onkol; 1995 May; 171(5):278-83. PubMed ID: 7770783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.
    van Dongen GA; Leverstein H; Roos JC; Quak JJ; van den Brekel MW; van Lingen A; Martens HJ; Castelijns JA; Visser GW; Meijer CJ
    Cancer Res; 1992 May; 52(9):2569-74. PubMed ID: 1568225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
    Bier H
    HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.